Role of glial cell-line derived neurotropic factor family receptor alpha2 in the actions of the glucagon-like peptides on the murine intestine.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Physiology - Gastrointestinal and Liver Physiology

• Publication date

  2007-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/AJPGI.00424.2006PMID 17585017
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2.

  2007cited by this paper
• The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.

  2006cited by this paper
• Myofibroblast matrix metalloproteinases activate the neutrophil chemoattractant CXCL7 from intestinal epithelial cells.

  2006cited by this paper
• Inhibitory effect of GLP-1 on gastric motility persists after vagal deafferentation in pigs

  2006cited by this paper
• Ileitis alters neuronal and enteroendocrine signalling in guinea pig distal colon

  2006cited by this paper
• Glucagon-like peptide-2: update of the recent clinical trials.

  2006cited by this paper
• GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow.

  2006cited by this paper
• Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes

  2006cited by this paper
• Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans

  2005cited by this paper
• GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors.

  2005cited by this paper
• Contrasting effects of tetraethylammonium and 4-aminopyridine on the gastrointestinal function of mice.

  2005cited by this paper
• Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice.

  2005cited by this paper
• Biologic actions and therapeutic potential of the proglucagon-derived peptides

  2005cited by this paper
• Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice.

  2005cited by this paper
• The effects of tegaserod, a 5-HT receptor agonist, on gastric emptying in a murine model of diabetes mellitus.

  2005cited by this paper
• Contraction induced by glicentin on smooth muscle cells from the human colon is abolished by exendin (9–39)

  2005cited by this paper
• Extrahypothalamic expression of the glucagon-like peptide-2 receptor is coupled to reduction of glutamate-induced cell death in cultured hippocampal cells.

  2004cited by this paper
• Mice expressing a dominant-negative Ret mutation phenocopy human Hirschsprung disease and delineate a direct role of Ret in spermatogenesis

  2004cited by this paper
• Glucagon‐like peptide‐2 inhibits antral emptying in man, but is not as potent as glucagon‐like peptide‐1

  2004cited by this paper
• Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells.

  2004cited by this paper
• Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety.

  2003cited by this paper
• Alimentary tract innervation deficits and dysfunction in mice lacking GDNF family receptor alpha2.

  2003cited by this paper
• GLP-1 and GLP-2 act in concert to inhibit fasted, but not fed, small bowel motility in the rat.

  2002cited by this paper
• The GDNF family: Signalling, biological functions and therapeutic value

  2002cited by this paper
• A new mathematical model for relative quantification in real-time RT-PCR.

  2001cited by this paper
• Glucagon-like Peptide (GLP)-2 Action in the Murine Central Nervous System Is Enhanced by Elimination of GLP-1 Receptor Signaling*

  2001cited by this paper
• Modulation of specific intestinal epithelial progenitors by enteric neurons

  2001cited by this paper
• Types of neurons in the enteric nervous system.

  2000cited by this paper
• Enzymatic- and renal-dependent catabolism of the intestinotropic hormone glucagon-like peptide-2 in rats.

  2000cited by this paper
• Enteroendocrine localization of GLP-2 receptor expression in humans and rodents.

  2000cited by this paper
• Co-localization of synaptophysin with different neuroendocrine hormones in the human gastrointestinal tract

  1999cited by this paper
• Lessons from genetically engineered animal models. II. Disorders of enteric neuronal development: insights from transgenic mice.

  1999cited by this paper
• Review article: roles played by 5‐hydroxytryptamine in the physiology of the bowel

  1999cited by this paper
• Retarded growth and deficits in the enteric and parasympathetic nervous system in mice lacking GFR alpha2, a functional neurturin receptor.

  1999cited by this paper
• Sympathetic pathways mediate GLP-1 actions in the gastrointestinal tract of the rat.

  1998cited by this paper
• Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs.

  1998cited by this paper
• Glucagon-like Peptide-1 Retards Gastric Emptying and Small Bowel Transit in the Rat (Effect Mediated Through Central or Enteric Nervous Mechanisms)

  1998cited by this paper
• Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity

  1998cited by this paper
• Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2.

  1997cited by this paper
• Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms.

  1997cited by this paper
• Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms.

  1997cited by this paper
• Intestinal growth-promoting properties of glucagon-like peptide-2 in mice.

  1997cited by this paper
• Role of prohormone convertases in the tissue-specific processing of proglucagon.

  1996cited by this paper
• Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

  1996cited by this paper
• Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse.

  1994cited by this paper
• Structure of the tertiary component of the myenteric plexus in the guinea-pig small intestine

  1993cited by this paper
• Glucagon-like peptide-1 7-36: a physiological incretin in man.

  1987cited by this paper
• Visualization of detailed acetylcholinesterase fiber and neuron staining in rat brain by a sensitive histochemical procedure.

  1986cited by this paper
• Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas.

  1986cited by this paper

• Contribution of Vasoactive Intestinal Peptide to the Depressant Effects of Glucagon-like Peptide-2 on Neurally Induced Contractile Responses in Mouse Ileal Preparations

  2025cites this paper
• Enteric nervous system as a therapeutic target in gastrointestinal disorders

  2025cites this paper
• GLP-1R signaling does not modify the severity of experimental graft versus host disease

  2025cites this paper
• Glucagon-like Peptide-2 Depresses Ileal Contractility in Preparations from Mice through Opposite Modulatory Effects on Nitrergic and Cholinergic Neurotransmission

  2024cites this paper
• The Possible Involvement of Glucagon-like Peptide-2 in the Regulation of Food Intake through the Gut–Brain Axis

  2024cites this paper
• A cholinergic neuroskeletal interface promotes bone formation during postnatal growth and exercise

  2022cites this paper
• Complementary and antagonistic effects of combined glucagon-like peptide-2 and glucagon-like peptide-1 receptor agonist administration on parameters relevant to short bowel syndrome.

  2021cites this paper
• Glucagon-like peptide-2 interferes with the neurally-induced relaxant responses in the mouse gastric strips through VIP release.

  2020cites this paper
• Glucagon-like Peptide-2 and the Regulation of Intestinal Growth and Function.

  2018cites this paper
• Glucagon-like peptide-2 modulates the nitrergic neurotransmission in strips from the mouse gastric fundus

  2017cites this paper
• GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity.

  2016cites this paper
• Multiple Roles of Ret Signaling in Mechanosensory Neuron Development

  2016cites this paper
• Cis and trans RET signaling control the survival and central projection growth of rapidly adapting mechanoreceptors

  2015cites this paper
• GLP-2: what do we know? What are we going to discover?

  2014cites this paper
• An Enteroendocrine Cell – Enteric Glia Connection Revealed by 3D Electron Microscopy

  2014cites this paper
• The effect of glucagon-like peptide-2 and intraluminal nutrients on intestinal adaptation in a rat model of short bowel syndrome

  2014cites this paper
• AUTHOR COPY ONLY Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet

  2013cites this paper
• Role of glucagon-like peptide-1 in the pathogenesis of experimental irritable bowel syndrome rat models.

  2013cites this paper
• Review article: a comparison of glucagon‐like peptides 1 and 2

  2013cites this paper
• Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet.

  2013cites this paper
• Proteomic Studies of Various Organs and Tissues of the Frilled Shark Chlamydoselachus anguineus

  2012influential citation
• The glucagon-like Peptide-2 Flava Mulé

  2012cites this paper
• Food intake in lean and obese mice after peripheral administration of glucagon-like peptide 2.

  2012cites this paper
• The Acute Regulation of Intestinal Chylomicron Secretion by Glucagon-like Peptides

  2012cites this paper
• The glucagon-like Peptide-2

  2011cites this paper
• Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion.

  2011cites this paper
• Gastric relaxation induced by glucagon-like peptide-2 in mice fed a high-fat diet or fasted.

  2011cites this paper
• Peripheral motor action of glucagon‐like peptide‐1 through enteric neuronal receptors

  2010cites this paper
• The Effect of Glucagon-like Peptide-2 on Insulin-like Growth Factor-1 in Murine Intestinal Subepithelial Myofibroblasts

  2010influential citation
• Role of cholinergic neurons in the motor effects of glucagon-like peptide-2 in mouse colon.

  2010cites this paper
• Augmentation of the ascending component of the peristaltic reflex and substance P release by glial cell line‐derived neurotrophic factor

  2010cites this paper
• Synergistic Effect of Glucagon-Like Peptide 2 (GLP-2) and of Key Growth Factors on the Proliferation of Cultured Rat Astrocytes. Evidence for Reciprocal Upregulation of the mRNAs for GLP-2 and IGF-I Receptors

  2009cites this paper
• Molecular identification of rapidly adapting mechanoreceptors and their developmental dependence on ret signaling.

  2009cites this paper
• Neurturin-Mediated Ret Activation Is Required for Retinal Function

  2008cites this paper